Clinical development success rates and social value of pediatric Phase 1 trials in oncology

OBJECTIVES: Drug development trials must fulfill social value requirement but no estimates of value provided by pediatric Phase 1 trials in oncology exist. These trials involve a particularly vulnerable population. Our objective was to assess of surrogates of social value of Phase 1 trials performed...

Descripción completa

Detalles Bibliográficos
Autores principales: Wasylewski, Mateusz T., Strzebonska, Karolina, Koperny, Magdalena, Polak, Maciej, Kimmelman, Jonathan, Waligora, Marcin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313751/
https://www.ncbi.nlm.nih.gov/pubmed/32579564
http://dx.doi.org/10.1371/journal.pone.0234911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313751/
https://www.ncbi.nlm.nih.gov/pubmed/32579564
http://dx.doi.org/10.1371/journal.pone.0234911

Ejemplares similares